Veru

VERU · NASDAQ · Pharmaceutical Preparations

Veru (VERU) · oqro.io/stocks/VERU · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.

How this filing works

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Want the short version?

Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.

Explain this page What did insiders at VERU buy and sell in the last 90 days?Which members of Congress and which funds traded VERU recently?

Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.

Insider trades around earnings

1 open-market purchase and 0 open-market sales by insiders of VERU between Nov 17, 2025 and today, placed against the company's last 4 earnings releases. The latest on file was filed Aug 10, 2026. The data provider lists the next release for Dec 15, 2026; that date may change.

PurchaseSale30 days before a release30 days after

Trades in the 30 days around each of the last earnings releases
Earnings release	30 days before	On the day	30 days after
Aug 10, 2026	None	None	1 purchase
May 13, 2026	None	None	None
Feb 11, 2026	None	None	None
Dec 17, 2025	None	None	None

K Gary Barnette, Chief Scientific Officer, Aug 13, 2026, about $4.8K. Bought 3 days after the company's previous earnings release on 2026-08-10Form 4

Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies

Insider trades · 19

Including 16 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only

Insider buying

K Gary BarnetteChief Scientific Officer

Filed 3mo ago

Bought

~$4.8K1,800 sh @ $2.69

First insider buy since Feb 2025Traded Aug 13 · filed 4 days later

Since the trade −22.6% · S&P 500 −3.0% · to Nov 13

Veru's Chief Scientific Officer paid $4.8K out of pocket for Veru shares. Shares held went up 360% with this purchase.